An Efficacy and Safety Study of Extended-Release (ER) Paliperidone in Adolescent Participants With Schizophrenia

NCT01009047 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

228

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Paliperidone extended release (ER)
DRUG: Aripiprazole

Sponsor

Janssen Research & Development, LLC